Intriguingly, it has been elucidated that STAT3 can be activated by IL-6 through Janus kinase 2 (JAK2), and IL-6/JAK2/STAT3 has been implied as a crucial accelerator for tumorigenesis and EMT in many cancer types, including HCC22. This evidence concerns the gene STAT3 and cancer.